Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06142955
NA

Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potential of TMS as an intervention for depression in individuals with Autism Spectrum Disorder (ASD).

Official title: Neuromodulation for Depression in Autism Spectrum Disorder

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-04-30

Completion Date

2026-12

Last Updated

2025-07-02

Healthy Volunteers

Yes

Interventions

DEVICE

MAGSTIM Rapid2 TMS system

The device will administer TMS pulses in bursts at fixed intervals for a total of 600 pulses over 190 seconds after first assessing the participants motor threshold (MT). During the sham stimulation condition, the TMS coil will be tilted 90° tangential to the scalp during the administration so that the orientation is not biologically active and will not elicit a muscle contraction. This sham condition will look and sound just like real TMS.

Locations (1)

Yale Psychiatric Hospital

New Haven, Connecticut, United States